Exelixis (EXEL) Long-Term Investments (2010 - 2026)

Exelixis (EXEL) recorded quarterly Long-Term Investments of $649.1 million in Q2 2026, up 7.54% quarter-over-quarter from $603.6 million in Q1 2026, and up 4.8% on a YoY basis from $619.4 million in Q2 2025.

Exelixis (EXEL) Long-Term Investments (2010 - 2026) Analysis & Trends

Exelixis' Long-Term Investments history runs 17 years deep, the most recent figure standing at $649.1 million for Q2 2026.

  • In Q2 2026, Long-Term Investments rose 4.8% year-over-year to $649.1 million; the TTM figure through Apr 2026 stood at $649.1 million (up 4.8% YoY), while the FY2026 annual figure was $603.6 million, down 5.29% from the prior year.
  • Long-Term Investments was $649.1 million for Q2 2026 at Exelixis, up from $603.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $838.6 million in Q2 2023 to a low of $404.5 million in Q2 2022.
  • Historically, Long-Term Investments has averaged $625.3 million across 5 years, with a median of $619.4 million in 2025.
  • The sharpest annual moves came in 2022 and 2024: Long-Term Investments jumped 103.91% in 2022, then plunged 48.45% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $756.7 million in 2022, then slipped by 3.7% to $728.7 million in 2023, then dropped by 28.17% to $523.4 million in 2024, then increased by 10.48% to $578.3 million in 2025, then climbed by 12.25% to $649.1 million in 2026.
  • The last three Long-Term Investments figures came in at $649.1 million (Q2 2026), $603.6 million (Q1 2026), and $578.3 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 5.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 649.14 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 649.14 Mn
Jan 2, 2026 603.60 Mn
Oct 3, 2025 578.29 Mn
Jul 4, 2025 594.65 Mn
Apr 4, 2025 619.44 Mn
Jan 3, 2025 637.29 Mn
Sep 27, 2024 523.42 Mn
Jun 28, 2024 432.31 Mn
Mar 29, 2024 629.56 Mn
Dec 29, 2023 728.72 Mn
Sep 29, 2023 811.68 Mn
Jun 30, 2023 838.62 Mn
Mar 31, 2023 806.62 Mn
Dec 30, 2022 756.73 Mn
Sep 30, 2022 551.74 Mn
Jul 1, 2022 463.89 Mn
Apr 1, 2022 404.54 Mn
Dec 31, 2021 371.11 Mn
Oct 1, 2021 362.22 Mn
Jul 2, 2021 345.61 Mn